Circulating Neuropeptide Y May Be a Biomarker for Diagnosing Atrial Fibrillation

Cardiology. 2023;148(6):593-595. doi: 10.1159/000533880. Epub 2023 Sep 25.

Authors

Marko Mornar Jelavic^{1

2}, Ovidiu Țica³, Hrvoje Pintaric^{1

2

4}, Otilia Țica^{3

5}

Affiliations

¹ Polyclinic Aviva, Zagreb, Croatia.
² The School of Dental Medicine, University of Zagreb, Zagreb, Croatia.
³ Emergency County Clinical Hospital of Oradea, Oradea, Romania.
⁴ The Traumatology Clinic, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
⁵ Institute of Cardiovascular Sciences, University of Birmingham, Medical School Birmingham, Birmingham, UK.

PMID: 37748446
DOI: 10.1159/000533880

No abstract available

MeSH terms

Atrial Fibrillation* / diagnosis
Biomarkers
Humans
Neuropeptide Y

Substances

Neuropeptide Y
Biomarkers